Papers
2
Total Citations
4
H-Index
2
About
Dr. Hak Choy is a leading authority in radiation oncology, whose career has been defined by pioneering work in the treatment of metastatic disease and the advancement of stereotactic body radiation therapy (SBRT). His research has fundamentally shaped how radiation is integrated into modern cancer care, particularly for challenging diagnoses. Dr. Choy’s major contributions include landmark clinical trials that established the safety and efficacy of dose-escalated SBRT for partial breast irradiation (PBI) following lumpectomy, offering a less invasive, highly precise treatment option for early-stage breast cancer. This work, detailed in his 2015 phase I dose escalation trial, has directly influenced clinical protocols worldwide. His foundational review on the role of radiotherapy in metastatic disease, published in 2011, remains a critical reference, synthesizing decades of progress to guide the field. While his most cited papers have garnered focused attention, his broader impact is reflected in a career spanning hundreds of publications and leadership roles that have shaped national treatment guidelines. Dr. Choy’s legacy is one of rigorous clinical investigation, translating innovative radiation techniques into tangible improvements in patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1The Role of Radiotherapy in the Treatment of Metastatic Disease2 citations · 2011
- 2